Category Archive for: ‘Fibromyalgia syndrome’

Milnacipran: A Serotonin and Norepinephrine Reuptake Inhibitor for the Management of Fibromyalgia Syndrome

July 1, 2009By Deborah A. Cios, PharmD, Julie E. Kim, PharmD, MBA, BCPSModern Medicine Fibromyalgia syndrome (FMS) is a condition classified by widespread chronic pain and is associated with fatigue, morning stiffness, and disordered sleep. Milnacipran is a serotonin and norepinephrine reuptake inhibitor (SNRI) that was recently approved by FDA for the management of FMS. In clinical trials, milnacipran has …

Read More